Feds sign $18M vaccine IT deal; Investors back Riffyn to make R&D reproducible;

> The FDA and the CDC awarded an $18 million contract for the Vaccine Adverse Event Reporting System. Article

> Riffyn raised $1.8 million to develop software that increases the reproducibility of R&D. Piece

> More than two-thirds of Big Pharma outsource the collection of data for research initiatives. Post

> UK Trade & Investment created a database and interactive map of the 5,000 life science companies and sites in its jurisdiction. Article

> Lab7 expanded its library of open source bioinformatics tools, BioBuilds. Release

> YPrime released a new version of its interactive response technology. News

> The Cambridge Crystallographic Data Centre struck deals for its system with 11 countries. Item

> Merge eClinical signed a deal that will see its eClinicalOS used to run a trial in India for the first time. Post

> GoBalto released a reporting tool for its clinical trial management package. News

> TransCelerate BioPharma published more evidence the traditional model of source data verification is inefficient. News

> PatientsLikeMe began a campaign to encourage people to share their health data. Release

> MIT Technology Review looked at the sequencing operation Regeneron ($REGN) is building. Feature